Literature DB >> 12603596

Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation.

Axel Trautmann1, Beate Rückert, Peter Schmid-Grendelmeier, Eva Niederer, Eva-B Bröcker, Kurt Blaser, Cezmi A Akdis.   

Abstract

Heterogeneity of lymphocyte populations demonstrates the diversity of cellular immune responses and provide a better understanding of the immune system. CD3+ CD8+ T cells exhibit a low CD8 expressing (CD8low) population in flow cytometric analysis of peripheral blood T cells. In healthy donors, this population consists of 0.2-7.0% of all CD8 T cells. The majority of the CD8low T cell population showed an elevated expression of CD25, CD45RA, and CD95L, and low levels of CD28, CD62L and CD45RO. Circulating CD8low T cells resemble cytotoxic effector cells because they express cytolytic mediators and are able to execute cytotoxicity. A restricted T cell receptor profile with increased Vbeta9, Vbeta14 and Vbeta23 expression was observed and the CD8low T cell population contain Epstein-Barr virus-specific T cells. Therefore, the CD8low population represent a subset of activated CD8 effector T cells, resulting most probably from a continuous and/or balanced immune response to intracellular pathogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603596      PMCID: PMC1782903          DOI: 10.1046/j.1365-2567.2003.01590.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

Review 1.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

2.  T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis.

Authors:  A Trautmann; M Akdis; D Kleemann; F Altznauer; H U Simon; T Graeve; M Noll; E B Bröcker; K Blaser; C A Akdis
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

3.  Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27- human T cells.

Authors:  P A Baars; L M Ribeiro Do Couto; J H Leusen; B Hooibrink; T W Kuijpers; S M Lens; R A van Lier
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

Review 4.  CD45: new jobs for an old acquaintance.

Authors:  J M Penninger; J Irie-Sasaki; T Sasaki; A J Oliveira-dos-Santos
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

5.  IFN-gamma and IL-4 regulate the growth and differentiation of CD8+ T cells into subpopulations with distinct cytokine profiles.

Authors:  A Noble; P A Macary; D M Kemeny
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

Review 6.  Granzymes: exogenous proteinases that induce target cell apoptosis.

Authors:  M J Smyth; J A Trapani
Journal:  Immunol Today       Date:  1995-04

7.  Age-related dysregulation in CD8 T cell homeostasis: kinetics of a diversity loss.

Authors:  J LeMaoult; I Messaoudi; J S Manavalan; H Potvin; D Nikolich-Zugich; R Dyall; P Szabo; M E Weksler; J Nikolich-Zugich
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

8.  Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes.

Authors:  M Vukmanovic-Stejic; B Vyas; P Gorak-Stolinska; A Noble; D M Kemeny
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

9.  Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones.

Authors:  J L Maryanski; C V Jongeneel; P Bucher; J L Casanova; P R Walker
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

10.  Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.

Authors:  V P Argaet; C W Schmidt; S R Burrows; S L Silins; M G Kurilla; D L Doolan; A Suhrbier; D J Moss; E Kieff; T B Sculley; I S Misko
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  18 in total

1.  CD8low CD100- T Cells Identify a Novel CD8 T Cell Subset Associated with Viral Control during Human Hantaan Virus Infection.

Authors:  Bei Liu; Ying Ma; Yusi Zhang; Chunmei Zhang; Jing Yi; Ran Zhuang; Haitao Yu; Angang Yang; Yun Zhang; Boquan Jin
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

2.  Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.

Authors:  J Judy Chang; Fiona Wightman; Angeline Bartholomeusz; Anna Ayres; Stephen J Kent; Joseph Sasadeusz; Sharon R Lewin
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

3.  Methanolic Extract of Sambucus ebulus Ameliorates Clinical Symptoms in Experimental Type 1 Diabetes through Anti-Inflammatory and Immunomodulatory Actions.

Authors:  Hamid Aghajanzadeh; Mohsen Abdolmaleki; Mohammad Ali Ebrahimzadeh; Nazanin Mojtabavi; Tahereh Mousavi; Maryam Izad
Journal:  Cell J       Date:  2021-08-29       Impact factor: 2.479

4.  High pathogen burden in childhood promotes the development of unconventional innate-like CD8+ T cells.

Authors:  Yves T Falanga; Michela Frascoli; Yasin Kaymaz; Catherine Forconi; John Michael Ong'echa; Jeffrey A Bailey; Leslie J Berg; Ann M Moormann
Journal:  JCI Insight       Date:  2017-08-03

5.  Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection.

Authors:  Michael A Eller; Nilu Goonetilleke; Boonrat Tassaneetrithep; Leigh Anne Eller; Margaret C Costanzo; Susan Johnson; Michael R Betts; Shelly J Krebs; Bonnie M Slike; Sorachai Nitayaphan; Kathleen Rono; Sodsai Tovanabutra; Lucas Maganga; Hannah Kibuuka; Linda Jagodzinski; Sheila Peel; Morgane Rolland; Mary A Marovich; Jerome H Kim; Nelson L Michael; Merlin L Robb; Hendrik Streeck
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

6.  Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.

Authors:  Coralie Chanvillard; Jason M Millward; Marta Lozano; Isabell Hamann; Friedemann Paul; Frauke Zipp; Jan Dörr; Carmen Infante-Duarte
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

7.  HTNV infection of CD8+ T cells is associated with disease progression in HFRS patients.

Authors:  Rongrong Liu; Ruixue Ma; Ziyu Liu; Haifeng Hu; Jiayi Shu; Peizhen Hu; Junjun Kang; Yusi Zhang; Mingwei Han; Xiaoxiao Zhang; Yiting Zheng; Qikang Ying; Shiyuan Hou; Wenqiu Wang; Fang Wang; Ning Cheng; Yan Zhuang; Jianqi Lian; Xia Jin; Xingan Wu
Journal:  Commun Biol       Date:  2021-06-02

8.  Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection.

Authors:  Jonathan M Beus; Salila S Hashmi; Saranya A Selvaraj; Danxia Duan; Linda L Stempora; Stephanie A Monday; Jennifer A Cheeseman; Kelly M Hamby; Samuel H Speck; Christian P Larsen; Allan D Kirk; Leslie S Kean
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

9.  Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats.

Authors:  Boaz Arzi; Emily Mills-Ko; Frank J M Verstraete; Amir Kol; Naomi J Walker; Megan R Badgley; Nasim Fazel; William J Murphy; Natalia Vapniarsky; Dori L Borjesson
Journal:  Stem Cells Transl Med       Date:  2015-11-18       Impact factor: 6.940

10.  Development of a Modular Assay for Detailed Immunophenotyping of Peripheral Human Whole Blood Samples by Multicolor Flow Cytometry.

Authors:  Paul F Rühle; Rainer Fietkau; Udo S Gaipl; Benjamin Frey
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.